<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/869"/><api:result><api:object category="publication" id="869" last-affected-when="2024-04-13T19:20:02.5+01:00" last-modified-when="2024-04-13T19:20:02.5+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/869" created-when="2010-05-17T13:46:31.257+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-04-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1462492" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1016/S0168-8510(00)00063-4" last-modified-when="2022-09-12T01:12:18.197+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Os</api:last-name><api:initials>N</api:initials><api:first-names>Nicole</api:first-names><api:separate-first-names><api:first-name>Nicole</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>Louis W</api:first-names><api:separate-first-names><api:first-name>Louis</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJG</api:initials><api:first-names>Henk JG</api:first-names><api:separate-first-names><api:first-name>Henk</api:first-name><api:first-name>J</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>Anton F</api:first-names><api:separate-first-names><api:first-name>Anton</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>Ben A</api:first-names><api:separate-first-names><api:first-name>Ben</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0168-8510(00)00063-4</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0168-8510(00)00063-4"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0168-8510(00)00063-4"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0168-8510</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Health Policy</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1016/s0168-8510(00)00063-4</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>24</api:day><api:month>4</api:month><api:year>2019</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record><api:record format="native" id="131483" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034012376" last-modified-when="2022-03-30T09:31:48.22+01:00"><api:citation-count>27</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Background: In the Netherlands a program on quality assurance in medical care has started in 1996. Clinical professionals, patient organizations and health services researchers formulate evidence based guidelines with a concomitant cost-effectiveness analysis. Objectives: To examine the cost-effectiveness of guideline recommendations for prevention of nephropathy in diabetes mellitus type 1 and 2. Research design: A semi-Markov compartment model was developed. Data from international publications on epidemiological surveys and randomized trials, together with national data on health care use and costs, were used to feed the model. A cohort of diabetes patients without renal disease enters the model. Measures: Complication (end-stage renal disease) free years, QALY's, and life-time medical costs per patient treated according to guideline recommendations or current anti-diabetic strategy. Results: Guideline treatment for type 1 diabetes yields 4.2 complication free life years, at a cost-effectiveness ratio of 13 500 (Dutch guilders) NLG per QALY. Type 2 diabetes patients gain 0.2 complication free life years at a cost-effectiveness ratio of 31 000 NLG per QALY. Conclusion: Guideline development for diabetes nephropathy, with concomitant cost-effectiveness calculations, has resulted in a transparent guideline with explicit information on long term cost and effects. The project has brought health care providers and health services researchers together. Copyright (C) 2000 Elsevier Science Ireland Ltd.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Van Os</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603965969</api:identifier></api:identifiers></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>LW</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006140107</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJG</api:initials><api:first-names>HJG</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>J</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Hospital De Weezenlanden</api:line><api:line type="city">Zwolle</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005093236</api:identifier></api:identifiers></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>AF</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006808019</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57191081993</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0168-8510(00)00063-4</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0168-8510(00)00063-4"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0168-8510(00)00063-4"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10720684</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0168-8510</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Health Policy</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: A cost effectiveness analysis of national clinical guidelines</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record><api:record format="native" id="869" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10720684" last-modified-when="2020-04-29T06:08:35.507+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>BACKGROUND: In the Netherlands a program on quality assurance in medical care has started in 1996. Clinical professionals, patient organizations and health services researchers formulate evidence based guidelines with a concomitant cost-effectiveness analysis. OBJECTIVES: To examine the cost-effectiveness of guideline recommendations for prevention of nephropathy in diabetes mellitus type 1 and 2. RESEARCH DESIGN: A semi-Markov compartment model was developed. Data from international publications on epidemiological surveys and randomized trials, together with national data on health care use and costs, were used to feed the model. A cohort of diabetes patients without renal disease enters the model. MEASURES: Complication (end-stage renal disease) free years, QALY's, and life-time medical costs per patient treated according to guideline recommendations or current anti-diabetic strategy. RESULTS: Guideline treatment for type 1 diabetes yields 4.2 complication free life years, at a cost-effectiveness ratio of 13 500 (Dutch guilders) NLG per QALY. Type 2 diabetes patients gain 0.2 complication free life years at a cost-effectiveness ratio of 31 000 NLG per QALY. CONCLUSION: Guideline development for diabetes nephropathy, with concomitant cost-effectiveness calculations, has resulted in a transparent guideline with explicit information on long-term cost and effects. The project has brought health care providers and health services researchers together.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Os</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="full">Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>LW</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJ</api:initials><api:first-names>HJ</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>AF</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10720684</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0168-8510(00)00063-4</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0168-8510(00)00063-4"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0168-8510(00)00063-4"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0168-8510</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Health Policy</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Child</api:keyword><api:keyword scheme="mesh">Child, Preschool</api:keyword><api:keyword scheme="mesh">Cohort Studies</api:keyword><api:keyword scheme="mesh">Cost of Illness</api:keyword><api:keyword scheme="mesh">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 1</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh">Diabetic Nephropathies</api:keyword><api:keyword scheme="mesh">Disease Progression</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Infant</api:keyword><api:keyword scheme="mesh">Infant, Newborn</api:keyword><api:keyword scheme="mesh">Markov Chains</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh">Preventive Health Services</api:keyword><api:keyword scheme="mesh">Quality-Adjusted Life Years</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Ireland</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0168851000000634</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>14</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record><api:record format="native" id="882112" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10720684" last-modified-when="2022-03-29T17:48:31.15+01:00"><api:citation-count>16</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Background&lt;/h4&gt;In the Netherlands a program on quality assurance in medical care has started in 1996. Clinical professionals, patient organizations and health services researchers formulate evidence based guidelines with a concomitant cost-effectiveness analysis.&lt;h4&gt;Objectives&lt;/h4&gt;To examine the cost-effectiveness of guideline recommendations for prevention of nephropathy in diabetes mellitus type 1 and 2.&lt;h4&gt;Research design&lt;/h4&gt;A semi-Markov compartment model was developed. Data from international publications on epidemiological surveys and randomized trials, together with national data on health care use and costs, were used to feed the model. A cohort of diabetes patients without renal disease enters the model.&lt;h4&gt;Measures&lt;/h4&gt;Complication (end-stage renal disease) free years, QALY's, and life-time medical costs per patient treated according to guideline recommendations or current anti-diabetic strategy.&lt;h4&gt;Results&lt;/h4&gt;Guideline treatment for type 1 diabetes yields 4.2 complication free life years, at a cost-effectiveness ratio of 13 500 (Dutch guilders) NLG per QALY. Type 2 diabetes patients gain 0.2 complication free life years at a cost-effectiveness ratio of 31 000 NLG per QALY.&lt;h4&gt;Conclusion&lt;/h4&gt;Guideline development for diabetes nephropathy, with concomitant cost-effectiveness calculations, has resulted in a transparent guideline with explicit information on long-term cost and effects. The project has brought health care providers and health services researchers together.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="NL"><api:line type="full">Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Os</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>LW</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-8639-5191</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJ</api:initials><api:first-names>HJ</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>AF</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0168-8510(00)00063-4</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0168-8510(00)00063-4"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0168-8510(00)00063-4"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1872-6054</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10720684</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0168-8510</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Health policy (Amsterdam, Netherlands)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Diabetic Nephropathies</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 1</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh">Disease Progression</api:keyword><api:keyword scheme="mesh">Markov Chains</api:keyword><api:keyword scheme="mesh">Cohort Studies</api:keyword><api:keyword scheme="mesh">Quality-Adjusted Life Years</api:keyword><api:keyword scheme="mesh">Cost of Illness</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Child</api:keyword><api:keyword scheme="mesh">Child, Preschool</api:keyword><api:keyword scheme="mesh">Infant</api:keyword><api:keyword scheme="mesh">Infant, Newborn</api:keyword><api:keyword scheme="mesh">Preventive Health Services</api:keyword><api:keyword scheme="mesh">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Practice Guidelines as Topic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record><api:record format="native" id="2739665" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1032500191" last-modified-when="2024-04-13T19:20:02.503+01:00"><api:citation-count>24</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>6</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Os</api:last-name><api:initials>N</api:initials><api:first-names>Nicole</api:first-names><api:separate-first-names><api:first-name>Nicole</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01236553251.33</api:identifier></api:identifiers></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>Louis W</api:first-names><api:separate-first-names><api:first-name>Louis</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01007423666.21</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJG</api:initials><api:first-names>Henk JG</api:first-names><api:separate-first-names><api:first-name>Henk</api:first-name><api:first-name>J</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Isala</api:line><api:line type="city">Zwolle</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.012626072417.24</api:identifier></api:identifiers></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>Anton F</api:first-names><api:separate-first-names><api:first-name>Anton</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01354204534.45</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>Ben A</api:first-names><api:separate-first-names><api:first-name>Ben</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01167771713.07</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0168-8510(00)00063-4</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0168-8510(00)00063-4"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0168-8510(00)00063-4"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10720684</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>4.78</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0168-8510</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Health Policy</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">4203 Health Services and Systems</api:keyword><api:keyword scheme="for-2020">42 Health Sciences</api:keyword><api:keyword scheme="rcdc">Prevention</api:keyword><api:keyword scheme="rcdc">Kidney Disease</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Comparative Effectiveness Research</api:keyword><api:keyword scheme="rcdc">Cost Effectiveness Research</api:keyword><api:keyword scheme="rcdc">Health Services</api:keyword><api:keyword scheme="rcdc">Diabetes</api:keyword><api:keyword scheme="hrcs-hc">Metabolic and endocrine</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Child</api:keyword><api:keyword scheme="mesh">Child, Preschool</api:keyword><api:keyword scheme="mesh">Cohort Studies</api:keyword><api:keyword scheme="mesh">Cost of Illness</api:keyword><api:keyword scheme="mesh">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 1</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh">Diabetic Nephropathies</api:keyword><api:keyword scheme="mesh">Disease Progression</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Infant</api:keyword><api:keyword scheme="mesh">Infant, Newborn</api:keyword><api:keyword scheme="mesh">Markov Chains</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh">Preventive Health Services</api:keyword><api:keyword scheme="mesh">Quality-Adjusted Life Years</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.57</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record><api:record format="native" id="241431" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000086177000001" last-modified-when="2024-03-14T05:42:25.47+00:00"><api:citation-count>23</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Os</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>LW</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">HSF-5254-2023</api:identifier><api:identifier scheme="researcherid">F-6254-2015</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJG</api:initials><api:first-names>HJG</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>J</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>AF</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000086177000001&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0168-8510(00)00063-4</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0168-8510(00)00063-4"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0168-8510(00)00063-4"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">299BY</api:identifier><api:identifier scheme="pubmed">10720684</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0168-8510</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>HEALTH POLICY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>cost-effectiveness analysis</api:keyword><api:keyword>guidelines</api:keyword><api:keyword>diabetes nephropathy</api:keyword><api:keyword>consensus</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item><api:item>Proceedings Paper</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record><api:record format="native" id="24430" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000086177000001" last-modified-when="2014-07-25T11:06:10.097+01:00"><api:citation-count>16</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Os</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>LW</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJG</api:initials><api:first-names>HJG</api:first-names><api:separate-first-names><api:first-name>H</api:first-name><api:first-name>J</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>AF</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0168-8510</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>HEALTH POLICY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>cost-effectiveness analysis</api:keyword><api:keyword>guidelines</api:keyword><api:keyword>diabetes nephropathy</api:keyword><api:keyword>consensus</api:keyword><api:keyword>NIDDM</api:keyword><api:keyword>COMPLICATIONS</api:keyword><api:keyword>MODEL</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record><api:record format="native" id="2108780" source-id="12" source-name="repec" source-display-name="RePEc" id-at-source="RePEc:eee:hepoli:v:51:y:2000:i:3:p:135-147" last-modified-when="2020-04-28T15:47:46.47+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>van Os</api:last-name><api:initials>N</api:initials><api:first-names>Nicole</api:first-names><api:separate-first-names><api:first-name>Nicole</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Niessen</api:last-name><api:initials>LW</api:initials><api:first-names>Louis W</api:first-names><api:separate-first-names><api:first-name>Louis</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bilo</api:last-name><api:initials>HJG</api:initials><api:first-names>Henk JG</api:first-names><api:separate-first-names><api:first-name>Henk</api:first-name><api:first-name>J</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Casparie</api:last-name><api:initials>AF</api:initials><api:first-names>Anton F</api:first-names><api:separate-first-names><api:first-name>Anton</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>Ben A</api:first-names><api:separate-first-names><api:first-name>Ben</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>135</api:begin-page><api:end-page>147</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>51</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Child</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Child, Preschool</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cohort Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cost of Illness</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Diabetes Mellitus, Type 1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Diabetic Nephropathies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Disease Progression</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Infant</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Infant, Newborn</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Markov Chains</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Preventive Health Services</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Quality-Adjusted Life Years</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Diabetic Nephropathies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Diabetes Mellitus, Type 1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Disease Progression</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Markov Chains</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cohort Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Quality-Adjusted Life Years</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cost of Illness</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Child</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Child, Preschool</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Infant</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Infant, Newborn</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Preventive Health Services</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Practice Guidelines as Topic</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">4203 Health Services and Systems</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">42 Health Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Prevention</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Kidney Disease</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Comparative Effectiveness Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cost Effectiveness Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Health Services</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Diabetes</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Metabolic and endocrine</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Child</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Child, Preschool</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cohort Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cost of Illness</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cost-Benefit Analysis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Diabetes Mellitus, Type 1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Diabetic Nephropathies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Disease Progression</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Infant</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Infant, Newborn</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Markov Chains</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Preventive Health Services</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Quality-Adjusted Life Years</api:keyword><api:keyword origin="record-data" source="wos-lite">cost-effectiveness analysis</api:keyword><api:keyword origin="record-data" source="wos-lite">guidelines</api:keyword><api:keyword origin="record-data" source="wos-lite">diabetes nephropathy</api:keyword><api:keyword origin="record-data" source="wos-lite">consensus</api:keyword><api:keyword origin="record-data" source="wos">cost-effectiveness analysis</api:keyword><api:keyword origin="record-data" source="wos">guidelines</api:keyword><api:keyword origin="record-data" source="wos">diabetes nephropathy</api:keyword><api:keyword origin="record-data" source="wos">consensus</api:keyword><api:keyword origin="record-data" source="wos">NIDDM</api:keyword><api:keyword origin="record-data" source="wos">COMPLICATIONS</api:keyword><api:keyword origin="record-data" source="wos">MODEL</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="for" origin="issn-inferred">1605 Policy and Administration</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Health Policy &amp; Services</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">4206 Public health</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">4407 Policy and administration</api:keyword></api:keywords></api:all-labels><api:journal issn="0168-8510" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972521" title="Health Policy"><api:records><api:record source-name="summary"><api:title>Health Policy</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/869/relationships"/></api:object></api:result></api:response>